We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Nilotinib effects on safety, tolerability, and biomarkers in Alzheimer's disease: A phase 2, double‐blind, randomized, placebo‐controlled trial: Human/Human trials: Anti‐amyloid.
- Authors
Turner, Raymond Scott; Hebron, Michaeline; Lawler, Abigail; Mundel, Elizabeth; Yusuf, Nadia; Starr, Nathan; Pagan, Fernando; Torres‐Yaghi, Yasar; Shi, Wangke; Mulki, Sanjana; Ferrante, Dalila; Matar, Sara; Liu, Xiaoguang; Esposito, Guiseppe; Berkowitz, Frank; Jiang, Xiong; Ahn, Jaeil; Moussa, Charbel E‐H
- Publication
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, Vol 16, Issue 11, p1
- ISSN
1552-5260
- Publication type
Article
- DOI
10.1002/alz.044628